Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment

J Neurol. 2024 Oct;271(10):7042-7045. doi: 10.1007/s00415-024-12661-1. Epub 2024 Sep 6.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Female
  • Humans
  • Leukoencephalitis, Acute Hemorrhagic* / drug therapy
  • Male
  • Treatment Outcome

Substances

  • tocilizumab
  • Antibodies, Monoclonal, Humanized